[[ data.name ]]
[[ data.ticker ]]
[[ data.price ]] [[ data.change ]] ([[ data.changePercent ]]%)
Low: [[ data.low ]]
High: [[ data.high ]]
About
History
Differences between Investing vs Trading
About
History
Differences between Investing vs Trading
Astrazeneca is a pharmaceutical company based in the United Kingdom. The company is famous for its work on cancer drugs, and it has a market capitalization of about $100 billion. Astrazeneca shares are traded on the London Stock Exchange, and the current share price is about $6000.
The company has been in business for over 100 years, and it is one of the largest pharmaceutical companies in the world. Astrazeneca is also one of the most profitable companies in the industry, with a net income of about $10 billion in 2020.
The company's products are sold in over 100 countries, and it has operations in all major markets. It is also one of the few companies that has its own research and development department. The company spends about $5 billion per year on research and development, and it has over 10,000 scientists working on new products. Astrazeneca's most famous product is Taxol, a cancer drug that was developed by the company's scientists. Taxol is used to treat breast cancer, ovarian cancer, and other types of cancer and was first approved by the FDA in 1992, and it is still one of the most popular cancer drugs on the market.
Astrazeneca is also known for its work on other drugs, such as Nexium, Seroquel, Crestor, and Symbicort. These drugs are used to treat a variety of conditions, including heart disease, schizophrenia, asthma, and COPD. Astrazeneca has a long history of success in the pharmaceutical industry, and it shows no signs of slowing down.
In the last years, due to the Covid-19 virus, Astrazeneca, Moderna and Pfizer have been in a race to release the vaccines. The first ones to realease it to the public were Pfizer and Moderna and later on Astrazeneca.
When it comes to astrazeneca shares, there are two main options for investors - buying and selling the actual shares or via CFD trading. Both have their own benefits and drawbacks, so it's important to understand the difference before making a decision. If you're simply looking to buy and hold astrazeneca shares, then investing is the most straightforward option. However, it's worth noting that you will need to pay stamp duty on any shares you purchase.
On the other hand, CFD trading offers greater flexibility, as you can choose to go long or short on the astrazeneca share price. Plus, with leverage, you can potentially make larger profits - but be aware that you could also end up making bigger losses. Ultimately, it comes down to your individual goals and risk tolerance as to which option is right for you.
| Swap long | [[ data.swapLong ]] points |
|---|---|
| Swap short | [[ data.swapShort ]] points |
| Spread min | [[ data.stats.minSpread ]] |
| Spread avg | [[ data.stats.avgSpread ]] |
| Min contract size | [[ data.minVolume ]] |
| Min step size | [[ data.stepVolume ]] |
| Commission and Swap | Commission and Swap |
| Leverage | Leverage |
| Trading Hours | Trading Hours |
* The spreads provided are a reflection of the time-weighted average. Though Skilling attempts to provide competitive spreads during all trading hours, clients should note that these may vary and are susceptible to underlying market conditions. The above is provided for indicative purposes only. Clients are advised to check important news announcements on our Economic Calendar, which may result in the widening of spreads, amongst other instances.
The above spreads are applicable under normal trading conditions. Skilling has the right to amend the above spreads according to market conditions as per the 'Terms and Conditions'.
Trade [[data.name]] with Skilling
All Hassle-free, with flexible trade sizes and with zero commissions!*
- Trade 24/5
- Minimum margin requirements
- No commission, only spread
- Fractional shares available
- Easy to use platform
*Other fees may apply.
FAQs
Which are the competitors of Astrazeneca shares?
There are several major competitors to Astrazeneca shares, including GlaxoSmithKline, Pfizer, and Merck. Each of these companies has a large share of the global pharmaceutical market, and all three are engaged in intense competition with one another. While Astrazeneca is a strong player in the industry, it faces stiff competition from these other major companies.
Who owns most Astrazeneca shares?
The largest shareholder of AstraZeneca is Fidelity Investments, which owns about 5% of the company. The second largest shareholder is BlackRock, which owns about 4% of AstraZeneca. Other major shareholders include Vanguard Group, Capital World Investors, and State Street Corporation. Together, these five investors own about 15% of AstraZeneca.
Do Astrazeneca shares pay dividends?
Yes, Astrazeneca shares pay dividends. The company has a long history of paying dividends, and investors have typically received significant dividend payments each year. Astrazeneca has increased its dividend payout ratio, meaning that a greater portion of its earnings is being paid out to shareholders in the form of dividends. This trend is likely to continue, given the company's strong financial position and its commitment to shareholder returns.
Of course, it is also important to remember that dividend payments are not guaranteed, and the company may choose to reduce or eliminate its dividend at any time. This decision would be made based on a number of factors, including the company's financial condition and business prospects. As such, investors should always conduct their own research before making any investment decisions.
Why Trade [[data.name]]
Make the most of price fluctuations - no matter what direction the price swings and without capital restrictions that come with buying the underlying asset.
CFDs
Equities
Capitalise on rising prices (go long)
Capitalise on falling prices (go short)
Trade with leverage
Hold larger positions than the cash you have at your disposal
Trade on volatility
No need to own the asset
No commissions
Just low spreads
Manage risk with in-platform tools
Ability to set take profit and stop loss levels
